(Q42995573)

English

Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study (English)

1 reference

Europe PubMed Central

12 November 2017

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

author name string

Vega P

1

1 reference

Europe PubMed Central

12 November 2017

Castro A

2

1 reference

Europe PubMed Central

12 November 2017

Hermida M

3

1 reference

Europe PubMed Central

12 November 2017

López Calvo S

4

1 reference

Europe PubMed Central

12 November 2017

Pedreira J

5

1 reference

Europe PubMed Central

12 November 2017

publication date

1 January 1999

1 reference

Europe PubMed Central

12 November 2017

Scandinavian Journal of Infectious Diseases

1 reference

Europe PubMed Central

12 November 2017

31

1 reference

Europe PubMed Central

12 November 2017

4

1 reference

Europe PubMed Central

12 November 2017

359-361

1 reference

Europe PubMed Central

12 November 2017

Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Ribavirin treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1080%2F00365549950163789

21 January 2018

Identifiers

10.1080/00365549950163789

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42995573&oldid=1976284284"